2 completed, 1 recruiting, 1 terminated. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Living Independence Through Functional Training Task-oriented resistance exercise - Mobility Limitation, Cognitive Impairment | Phase 1 / Phase 2 | Recruiting | University of Florida | 15 | 2026-01-06 | 2026-07-31 |
| Heat Therapy, Functional Capacity, and Vascular Health in Older Adults Home-based leg heat therapy, Home-based sham therapy - Aging Well, Walking, Difficulty | Phase 1 / Phase 2 | Completed | University of North Texas Health Science Center | 21 | 2022-11-03 | 2026-06-05 |
| Increasing Activity for Veterans With PTSD Physical Activity - Stress Disorders, Post-Traumatic | Phase 1 | Completed | VA Office of Research and Development | 24 | 2021-03-02 | 2025-03-04 |
| A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility reldesemtiv, Placebo - Mobility Limitation | Phase 1 | Terminated | Astellas Pharma Global Development, Inc. | 42 | 2017-06-28 | 2024-10-31 |
Motor Activity (2) · Cognitive Dysfunction (1) · Hyperemia (1) · Hyperthermia (1) · Stress Disorders, Post-Traumatic (1)
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Behavior (2) · Mental Disorders (2) · Body Temperature Changes (1) · Cardiovascular Diseases (1) · Cognition Disorders (1) · Heat Stress Disorders (1) · Neurocognitive Disorders (1) · Stress Disorders, Traumatic (1) · Trauma and Stressor Related Disorders (1) · Vascular Diseases (1) · Wounds and Injuries (1)
Exercise (1) · reldesemtiv (1)
Astellas Pharma Global Development, Inc. (1) · University of Florida (1) · University of North Texas Health Science Center (1) · VA Office of Research and Development (1)
United States (4)
Chiung-ju Liu Associate Professor, phD (1) · Wei Denise Duan-Porter, MD PhD (1)